Literature DB >> 18696039

[Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes].

M Autenrieth1, R Nawroth, S Semmlack, J E Gschwend, M Retz.   

Abstract

Detection of metastases in lymph nodes is an important prognostic factor for progression-free survival in bladder cancer patients. Patients undergoing radical cystectomy with pelvic lymphadenectomy are randomized in the LEA study (AUO AB 25/02) into two groups receiving standard (obturator and external nodes) or extended lymphadenectomy (complete pelvic nodes up to the inferior mesenteric artery).The aim of this study is the detection of lymph node metastases that are not identified with classic pathological methods using RT-PCR as a highly sensitive and specific method. For detection of occult disseminated tumor cells we analyze the expression of the tumor markers cytokeratin 20 (CK-20), uroplakin II (UP II), mucin 2 (MUC2), and mucin 7 (MUC7).We examined 315 lymph nodes from 19 cystectomy patients for the expression of CK-20. In 93 lymph nodes CK-20 expression was detected whereas only 18 lymph nodes were histopathologically positive. More than one third of CK-20-positive lymph node metastases were located outside the standard lymphadenectomy field. We did not detect any skip lesions. Follow-up data will validate if there is a correlation between detection of occult disseminated tumor cells and progression-free survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18696039     DOI: 10.1007/s00120-008-1829-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  13 in total

1.  Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era.

Authors:  Richard E Hautmann; Jürgen E Gschwend; Robert C de Petriconi; Martina Kron; Bjoern G Volkmer
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

2.  Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.

Authors:  M Retz; J Lehmann; C Röder; K Weichert-Jacobsen; T Loch; E Romahn; C Lühl; H Kalthoff; M Stöckle
Journal:  Eur Urol       Date:  2001-05       Impact factor: 20.096

3.  Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.

Authors:  Xiuxian Wu; Yoshiyuki Kakehi; Yu Zeng; Rikiya Taoka; Hiroyuki Tsunemori; Mashashi Inui
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

4.  Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.

Authors:  S R Potter; L A Mangold; M J Shue; D C Taylor; K L Lecksell; J I Epstein; P C Walsh; A W Partin
Journal:  Cancer       Date:  2000-12-15       Impact factor: 6.860

5.  Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection.

Authors:  Nivedita Bhatta Dhar; Steven C Campbell; Craig D Zippe; Ithaar H Derweesh; Alwyn M Reuther; Amr Fergany; Eric A Klein
Journal:  BJU Int       Date:  2006-09-06       Impact factor: 5.588

6.  Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.

Authors:  Hillary L Copp; Joseph L Chin; Mark Conaway; Dan Theodorescu
Journal:  Cancer       Date:  2006-07-01       Impact factor: 6.860

7.  Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.

Authors:  Toshifumi Kurahashi; Isao Hara; Nobutoshi Oka; Sadao Kamidono; Hiroshi Eto; Hideaki Miyake
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

Review 8.  Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection.

Authors:  Henrik Suttmann; Jörn Kamradt; Jan Lehmann; Michael Stöckle
Journal:  BJU Int       Date:  2007-12       Impact factor: 5.588

9.  Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.

Authors:  Margitta Retz; Jan Lehmann; Celine Szysnik; Stephanie Zwank; Thorsten Venzke; Christian Röder; Holger Kalthoff; Carol Basbaum; Michael Stöckle
Journal:  Eur Urol       Date:  2004-03       Impact factor: 20.096

Review 10.  Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.

Authors:  Jan Lehmann; Margitta Retz; Michael Stöckle
Journal:  World J Urol       Date:  2002-02-27       Impact factor: 4.226

View more
  3 in total

1.  [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].

Authors:  T Martini; P Ströbel; A Steidler; N Petrakopoulou; P Erben; C Bolenz
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

Review 2.  [Molecular lymph node staging in prostate and bladder cancer].

Authors:  M M Heck; M Retz; R Nawroth
Journal:  Urologe A       Date:  2014-04       Impact factor: 0.639

Review 3.  Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer.

Authors:  Robert Svatek; Pascal Zehnder
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.